Albuterol HFA Related Published Studies
Well-designed clinical trials related to Albuterol HFA
Albuterol and exercise effects on ankle extensor strength during 40 days of unloading. [2008.06]
Exposure to tobacco smoke increases leukotriene E4-related albuterol usage and response to montelukast. [2008.06]
Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]
Comparison of nebulized epinephrine to albuterol in bronchiolitis. [2008.04]
The Effects of Nebulized Albuterol on Esophageal Function in Asthmatic Patients. [2008.02.13]
Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy. [2008.01.08]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]
An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]
Comparison of the dose response to levalbuterol with and without pretreatment with S-albuterol after methacholine-induced bronchoconstriction. [2007.09]
Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis. [2007.06.02]
Comparison of intravenous terbutaline versus normal saline in pediatric patients on continuous high-dose nebulized albuterol for status asthmaticus. [2007.06]
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma. [2007.05.17]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]
Population pharmacokinetics of (R)-albuterol and (S)-albuterol in pediatric patients aged 4-11 years with asthma. [2007]
A randomized, clinical trial comparing the efficacy of continuous nebulized albuterol (15 mg) versus continuous nebulized albuterol (15 mg) plus ipratropium bromide (2 mg) for the treatment of acute asthma. [2006.11]
Evaluation of the efficacy and safety of levalbuterol in subjects with COPD. [2006.08]
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. [2006.05]
Assessing the Effects of Racemic and Single-Enantiomer Albuterol on Airway Secretions in Long-term Intubated Patients. [2006.01]
Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial. [2006.01]
Evaluation of the safety and efficacy of levalbuterol in 2-5-year-old patients with asthma. [2005.12]
Helium/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial. [2005.11]
Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. [2005.10]
Regular vs ad-lib albuterol for patients hospitalized with acute asthma. [2005.09]
Beneficial effects of albuterol therapy driven by heliox versus by oxygen in severe asthma exacerbation. [2005.09]
Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis. [2005.08]
Levalbuterol versus racemic albuterol in the treatment of acute exacerbation of asthma in children. [2005.07]
A randomized controlled trial to assess the optimal dose and effect of nebulized albuterol in acute exacerbations of COPD. [2005.07]
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. [2005.07]
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]
The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study. [2005.05]
Albuterol aids resistance exercise in reducing unloading-induced ankle extensor strength losses. [2005.05]
The study of in vitro-in vivo correlation: pharmacokinetics and pharmacodynamics of albuterol dry powder inhalers. [2005.01]
Comparison of the bronchodilating effects of formoterol and albuterol delivered by hydrofluoroalkane pressurized metered-dose inhaler. [2005]
Well-designed clinical trials possibly related to Albuterol HFA
Stability of asthma control with regular treatment: an analysis of the Gaining Optimal Asthma controL (GOAL) study. [2008.07]
Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD. [2008.07]
The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. [2008.06.01]
Budesomide/ formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation. [2008.06]
Comparison of adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler and fixed-dose fluticasone propionate/salmeterol dry powder inhaler in asthma patients. [2008.06]
Association of corticotropin-releasing hormone receptor-2 genetic variants with acute bronchodilator response in asthma. [2008.05]
Bronchodilator responsiveness in patients with COPD. [2008.04]
Aerosolized salbutamol accelerates the resolution of pulmonary edema after lung resection. [2008.04]
AIR inhaled insulin versus subcutaneous insulin: pharmacokinetics, glucodynamics, and pulmonary function in asthma. [2008.04]
Rapid corticosteroid effect on beta(2)-adrenergic airway and airway vascular reactivity in patients with mild asthma. [2008.03]
Endurance shuttle walking test: responsiveness to salmeterol in COPD. [2008.03]
In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury. [2008.03]
Salmeterol vs. formoterol: a comparison of rapid bronchodilator effect in a randomized controlled trial. [2008.03]
The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. [2008.01.01]
Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma. [2008.01]
Dose response of inhaled salbutamol on exercise performance and urine concentrations. [2008.01]
Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma. [2008.01]
Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison. [2008]
Comparison of bronchodilatory properties of transdermal and inhaled long-acting beta 2-agonists. [2008]
Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study. [2008]
Once versus twice daily formoterol via Novolizer for patients with moderate to severe COPD--a double-blind, randomised, controlled trial. [2008]
Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD. [2008]
Salmeterol/Fluticasone Propionate via Diskustrade mark Once Daily versus Fluticasone Propionate Twice Daily in Patients with Mild Asthma not Previously Receiving Maintenance Corticosteroids. [2008]
Agreement between two methods for assessing bioequivalence of inhaled salbutamol. [2008]
Is Salamol less effective than Ventolin? A randomised, blinded, crossover study in New Zealand. [2007.12.14]
Efficacy and safety of single therapeutic and supratherapeutic doses of indacaterol versus salmeterol and salbutamol in patients with asthma. [2007.12]
The Efficacy and Safety of Combination Salmeterol (50 {micro}g)/Fluticasone Propionate (500 {micro}g) Inhalation Twice Daily Via Accuhaler in Chinese Patients With COPD. [2007.12]
Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone. [2007.12]
Comparison of the efficacy of salmeterol/fluticasone propionate combination in Japanese and Caucasian asthmatics. [2007.12]
Determination of the relative bioavailability of salbutamol to the lungs following inhalation from dry powder inhaler formulations containing drug substance manufactured by supercritical fluids and micronization. [2007.11]
Comparison of add-on therapy to inhaled fluticasone propionate in children with asthma: residual volume and exhaled nitric oxide as outcome measures. [2007.11]
Comparison of traditional and abbreviated salbutamol aerosol therapy using a new spacer mouth mask. [2007.11]
Determinants of response to fluticasone propionate and salmeterol/fluticasone propionate combination in the Gaining Optimal Asthma controL study. [2007.11]
Effect of salmeterol/fluticasone propionate on airway inflammation in COPD: a randomised controlled trial. [2007.11]
[Benefits of a home-based pulmonary rehabilitation program for patients with severe chronic obstructive pulmonary disease] [2007.11]
Initiation of maintenance treatment with salmeterol/fluticasone propionate 50/100 microg bd versus fluticasone propionate 100 microg bd alone in patients with persistent asthma: integrated analysis of four randomised trials. [2007.11]
Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial. [2007.10]
Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. [2007.10]
Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma. [2007.09.27]
Early administration of two intravenous bolus of aminophylline added to the standard treatment of children with acute asthma. [2007.09.13]
Intranasal ciclesonide coadministration with inhaled fluticasone propionate-salmeterol does not suppress cortisol in allergic rhinitis patients. [2007.09]
Fast onset of effect of budesonide/formoterol versus salmeterol/fluticasone and salbutamol in patients with chronic obstructive pulmonary disease and reversible airway obstruction. [2007.09]
Single-dose montelukast or salmeterol as protection against exercise-induced bronchoconstriction. [2007.09]
Long-term asthma treatment guided by airway hyperresponsiveness in children: a randomised controlled trial. [2007.09]
Swimming and persons with mild persistant asthma. [2007.08.17]
Tiotropium is less likely to induce oxygen desaturation in stable COPD patients compared to long-acting beta2-agonists. [2007.08]
Comparison of the effects of salmeterol/fluticasone propionate with fluticasone propionate on airway physiology in adults with mild persistent asthma. [2007.07.14]
Salmeterol/fluticasone stable-dose treatment compared with formoterol/budesonide adjustable maintenance dosing: impact on health-related quality of life. [2007.07.04]
Is there any point in a corticosteroid treatment of intermittent asthma? [2007.07.03]
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. [2007.07]
Randomized trial of spacers in asthma. [2007.07]
Initiation of maintenance therapy with salmeterol/fluticasone propionate combination therapy in moderate asthma: a comparison with fluticasone propionate. [2007.07]
Effects of acute salbutamol intake during supramaximal exercise in women. [2007.07]
Canadian economic evaluation of budesonide-formoterol as maintenance and reliever treatment in patients with moderate to severe asthma. [2007.07]
Placebo response in asthma: a robust and objective phenomenon. [2007.06]
The effect of regular versus on-demand desloratadine treatment in children with allergic rhinitis. [2007.06]
A proof of concept study to evaluate stepping down the dose of fluticasone in combination with salmeterol and tiotropium in severe persistent asthma. [2007.06]
Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone. [2007.06]
Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain. [2007.06]
A comparative study of patients' preferences and sensory perceptions of three forms of inhalers among Thai asthma and COPD patients. [2007.06]
Randomized comparison of strategies for reducing treatment in mild persistent asthma. [2007.05.17]
A randomised, double-blind, placebo-controlled study to evaluate the role of formoterol in the management of acute asthma. [2007.05]
The additive effect of theophylline on a combination of formoterol and tiotropium in stable COPD: a pilot study. [2007.05]
Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma. [2007.05]
[Comparative clinical study of dexamethasone vs. nebulized salbutamol in acute bronchiolitis] [2007.05]
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. [2007.04.17]
|
